Olink Proteomics on Muck Rack

Olink Proteomics

As seen in: PLOS ONE, LabRoots, SelectScience
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Olink

Contact Olink, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

[Webinar] Mass Spec Enables More Definitive Biologics Drug Discovery and Optimization

|
By Olink Proteomics
| LabRoots Verified
Lei Guo Ph.D. Senior Director, WuXi Biologics CRO Services BIOGRAPHY Date: November 19, 2025 Time: 2 pm (GMT), 3 pm (CET) The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as post-translational modifications (PTMs) and sequence variants can affect product quality, safety, and efficacy. Mass Spec (MS) has emerged as a powerful tool for structure and function analysis with unmatched precision and high-throughput (HTP) capabilities.
Open in Who Shared Issue with article?

Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21)

|
By Agneta Siegbahn, Niclas Eriksson, Olink Proteomics, Erika Assarsson
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Siegbahn A, Eriksson N, Assarsson E, Lundberg M, Ballagi A, Held C, et al. (2023) Development and validation of a quantitative Proximity Extension Assay instrument with 21 proteins associated with cardiovascular risk (CVD-21). PLoS ONE 18(11): e0293465.
Open in Who Shared Issue with article?

Olink® Proteomics

|
By Olink Proteomics
| LabRoots Verified
Grab your cup of coffee and join us for the next Multiomics Coffee Break on 15th January at 10.00AM EST/4.00PM CET, with a presentation from Discovery Life Sciences, an Olink Certified Servi... In this webinar, Dr. Clarissa Yates, CEO of Ketim Therapeutics, will share her exciting results from a proteomics pilot study exploring biomarkers associated with postpartum depression (PPD)...
Open in Who Shared Issue with article?
See all 6 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified